Skip to content

Pharmacokinetics of Omeprazole Combination Capsules in Healthy Chinese Volunteers

Pharmacokinetics of Omeprazole Combination Capsules in Healthy Chinese Volunteers

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-IIR-16008091
Enrollment
Unknown
Registered
2016-03-14
Start date
2013-04-17
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastric acid related diseases

Interventions

Group A:In the fasting state, single and multiple oral doses of the reference formulation 20mg firstly, then single and multiple oral doses of the test preparation 20mg, then single and multiple oral
Group B:In the fasting state, single and multiple oral doses of the test formulation 20mg firstly, then single and multiple oral doses of the reference preparation 20mg, then single and multiple oral

Sponsors

The first affiliated hospital, School of Medicine, Zhejiang University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
22 Years to 29 Years

Inclusion criteria

Inclusion criteria: (1) Healthy subjects; (2) Subject is 18~40 years old and the age difference should less than 10 years in the same batch, the sexual portion is equal; (3) BMI in range of 19~25kg/m2 [BMI=weight (kg)/height 2(m2)]; (4) Subject is able to communicate with investigator well and comply with requires of study; (5) Subject should have a strong understand of the object, nature and eventuality of trial, volunteer for the trial and sign the informed consent.

Exclusion criteria

Exclusion criteria: (2) Blood donation in the last 1 month or intend to donate blood in the following 1 month; (3) Used any medicine in the last 2 weeks; (4) Any medical history of cardiovascular, hepatic, kidney, gastrointestinal tract, and nervous system, metabolic disturbance, etc (5) The general examination and blood pressure, heart rate and respiratory conditions are not qualified; (6) Physical examination found that there are any significant clinical symptoms; (7) Laboratory test (hematology, urine analysis, blood biochemistry, ECG examination and the four markers) results judged as Heart, liver and kidney dysfunction; (8) Women in gestation period and lactation period, and menstrual period; (9) Allergic constitution: the persons allergic to two or more medicines, food and pollen or ingredients of investigator produc; (10) Drug abusers, tobacco and alcohol addiction; (11) Unsuitable to participate in the trial considered by the researchers.

Design outcomes

Primary

MeasureTime frame
AUCtn;Cmax;Tmax;t1/2z;Cl/F;Vz/F;AUCss;Css_min;Cavg;fluctuation%;

Countries

China

Contacts

Public ContactJianzhong Shentu
stjz@zju.edu.cn+86 13957111817

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026